when was first glp 1 approved World Pharma Today | π The FDA has the GLP-1 pill for obesity developed by Novo Nordisk, expected to be available by 2026. This treatment, with a Evolution of GLPβ1 Receptor Agonists
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
























